664324-22-5

Basic information

• Product Name: Benzoic acid, 4-[(2-formyl-3-hydroxyphenoxy)methyl]-, methyl ester
• Synonyms: 4-(2-Formyl-3-hydroxy-phenoxymethyl)-benzoic acid methyl ester
• CAS NO: 664324-22-5
• Molecular Formula: C16H14O5
• Molecular Weight: 286.284
• Mol File: 664324-22-5.mol
• Article Data: 4

Chemical Properties

• Melting Point: 123 - 125 °C (aq. ethanol)
• Boiling Point: 457.2±40.0 °C(Predicted)
• Density: 1.288±0.06 g/cm3(Predicted)
• CAS DataBase Reference: Benzoic acid, 4-[(2-formyl-3-hydroxyphenoxy)methyl]-, methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic acid, 4-[(2-formyl-3-hydroxyphenoxy)methyl]-, methyl ester(664324-22-5)
• EPA Substance Registry System: Benzoic acid, 4-[(2-formyl-3-hydroxyphenoxy)methyl]-, methyl ester(664324-22-5)

Safety Data

• Hazardous Substances Data: 664324-22-5(Hazardous Substances Data)

Upstream product

• 2417-72-3 Methyl 4-(bromomethyl)benzoate 
• 387-46-2 2,6-dihydroxybenzaldehyde 
• 67-56-1 methanol 
• 84290-27-7 4-(2-formyl-3-hydroxyphenoxymethyl)benzoic acid 
• 3392-97-0 2,6-dimethoxybenzaldehyde 
• 108-46-3 recorcinol 
• 199388-03-9 6-Methoxymethoxy-2-tetrahydropyran-2-yloxybenzaldehyde 
• 199388-01-7 2-methoxy-6-(tetrahydro-2H-pyran-2-yloxy)benzaldehyde 
• 84290-49-3 2-hydroxy-6-(methoxymethoxy)benzaldehyde 
• 155351-64-7 3-(methoxymethoxy)phenyl 2-tetrahydropyranyl ether 
• 18066-10-9 3-methoxymethyloxyphenol 
• 30778-86-0 1-methoxy-3-tetrahydropyran-2-yloxybenzene 
• 150-19-6 O-methylresorcine 
• 700-44-7 6-methoxysalicylaldehyde 

Downstream Products

• 84290-27-7 4-(2-formyl-3-hydroxyphenoxymethyl)benzoic acid 

Relevant articles and documents

Tucaresol derivative and use thereof

The invention discloses a tucaresol derivative compound, a composition comprising the tucaresol derivative compound, a method for enhancing an immune response in an individual by administering the tucaresol derivative compound or by co-administering the tucaresol derivative compound and one or more additional agents, and use of the tucaresol derivative compound and the composition comprising the tucaresol derivative compound in preparation of a medicament for treating cancer in an individual or enhancing an immune response in an individual.

NOVEL USE OF BENZOTHIAZOLE DERIVATIVES

The use of compounds of formula (I) wherein X, A, B, D, R1 and R2 are as defined in the Specification and pharmaceutically acceptable salts thereof in the manufacture of a medicament for the treatment or prophylaxis of diseases or conditions in which inhibition of kinase Itk activity is beneficial is disclosed. Certain novel compounds of formula (I), together with processes for their preparation, compositions containing them and their use in therapy are also disclosed.